MTHFD2 and breast carcinoma: MTHFD2 (methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2) is a source of carbon units for purine synthesis in rapidly growing cancer cells and has been associated with poor prognosis in patients with breast cancer [45, 46].